Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
0.887
-0.042 (-4.55%)
Apr 29, 2026, 10:28 AM EDT - Market open
Jasper Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Cash & Equivalents | 28.69 | 71.64 | 86.89 | 38.25 | 84.7 | Upgrade
|
| Cash & Short-Term Investments | 28.69 | 71.64 | 86.89 | 38.25 | 84.7 | Upgrade
|
| Cash Growth | -59.95% | -17.55% | 127.16% | -54.84% | 326.96% | Upgrade
|
| Other Receivables | - | - | 0.25 | 0.91 | 0.55 | Upgrade
|
| Receivables | - | - | 0.25 | 0.91 | 0.55 | Upgrade
|
| Prepaid Expenses | 1.63 | 1.57 | 1.19 | 1.61 | 2.29 | Upgrade
|
| Other Current Assets | 4.32 | 2.6 | 0.62 | 0.96 | 0.29 | Upgrade
|
| Total Current Assets | 34.65 | 75.81 | 88.94 | 41.73 | 87.83 | Upgrade
|
| Property, Plant & Equipment | 0.6 | 2.85 | 4.19 | 5.45 | 4.83 | Upgrade
|
| Other Long-Term Assets | 0.53 | 1.24 | 1.76 | 1.18 | 0.99 | Upgrade
|
| Total Assets | 35.78 | 79.9 | 94.89 | 48.36 | 93.65 | Upgrade
|
| Accounts Payable | 6.22 | 4.03 | 4.15 | 1.77 | 3.92 | Upgrade
|
| Accrued Expenses | 5.63 | 9.7 | 6.94 | 4.24 | 2.81 | Upgrade
|
| Current Portion of Leases | 1.24 | 1.09 | 0.97 | 0.87 | 0.51 | Upgrade
|
| Other Current Liabilities | 0.12 | 0.42 | 0.32 | 0.19 | 0.79 | Upgrade
|
| Total Current Liabilities | 13.2 | 15.24 | 12.37 | 7.07 | 8.02 | Upgrade
|
| Long-Term Leases | - | 0.72 | 1.81 | 2.79 | 2.38 | Upgrade
|
| Long-Term Unearned Revenue | 2.26 | 2.26 | 2.26 | 2.26 | 0.6 | Upgrade
|
| Other Long-Term Liabilities | 16.16 | - | - | 0.26 | 13.14 | Upgrade
|
| Total Liabilities | 31.63 | 18.23 | 16.45 | 12.37 | 24.14 | Upgrade
|
| Common Stock | 0 | 0 | 0 | - | 0 | Upgrade
|
| Additional Paid-In Capital | 320.82 | 302.54 | 248.04 | 141.12 | 136.96 | Upgrade
|
| Retained Earnings | -316.67 | -240.87 | -169.6 | -105.14 | -67.45 | Upgrade
|
| Total Common Equity | 4.15 | 61.67 | 78.44 | 35.99 | 69.52 | Upgrade
|
| Shareholders' Equity | 4.15 | 61.67 | 78.44 | 35.99 | 69.52 | Upgrade
|
| Total Liabilities & Equity | 35.78 | 79.9 | 94.89 | 48.36 | 93.65 | Upgrade
|
| Total Debt | 1.24 | 1.81 | 2.79 | 3.65 | 2.89 | Upgrade
|
| Net Cash (Debt) | 27.46 | 69.82 | 84.1 | 34.6 | 81.82 | Upgrade
|
| Net Cash Growth | -60.68% | -16.98% | 143.07% | -57.71% | 349.19% | Upgrade
|
| Net Cash Per Share | 1.43 | 4.79 | 8.06 | 9.48 | 71.81 | Upgrade
|
| Filing Date Shares Outstanding | 28 | 15.02 | 15.06 | 10.94 | 4.95 | Upgrade
|
| Total Common Shares Outstanding | 28 | 15.02 | 11.16 | 4.62 | 4.95 | Upgrade
|
| Working Capital | 21.45 | 60.57 | 76.56 | 34.67 | 79.81 | Upgrade
|
| Book Value Per Share | 0.15 | 4.11 | 7.03 | 7.78 | 14.04 | Upgrade
|
| Tangible Book Value | 4.15 | 61.67 | 78.44 | 35.99 | 69.52 | Upgrade
|
| Tangible Book Value Per Share | 0.15 | 4.11 | 7.03 | 7.78 | 14.04 | Upgrade
|
| Machinery | 2.21 | 2.88 | 2.62 | 2.35 | 1.92 | Upgrade
|
| Leasehold Improvements | 2.71 | 2.71 | 2.48 | 2.48 | 2.06 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.